CHARLES JOST: Open Payments
NPI 1316608706 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 40 payments from 16 companies in 2025. Trend: 2023 $1,125 · 2024 $1,081 · 2025 $998
Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $251 |
| AstraZeneca Pharmaceuticals LP | 4 | $188 |
| Vanda Pharmaceuticals Inc. | 2 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $61 |
| PFIZER INC. | 4 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
| Lilly USA, LLC | 3 | $50 |
| Cranial Technologies, Inc | 2 | $39 |
| ABBVIE INC. | 2 | $33 |
| Medtronic, Inc. | 1 | $27 |
Products named: Wegovy, BREZTRI, FANAPT, CAPLYTA, XIFAXAN, PREVNAR 20, Doc Band, MOUNJARO.
Industry payments across KS — which companies pay providers there.
